Events & presentations

Financial & IR calendar

General Shareholders’ Meeting
POSTPONED

30 May 2024

(initially planned for 30 May 2024, postponed to a later date to be determined)

Half year results 2024

26 September 2024

Investor Relations
presentation

Investor Relations
factsheet

Financial
results & reports

Presentations & webcasts

Material
Date
View

2023 Half Year Results Webcast

26 September 2023

2022 Annual Results Webcast

7 March 2023

Donesta partnership webcast

20 December 2022

Pharmaceuticals in the Environment: Current challenges and tomorrow’s solutions to protect wildlife

8 November 2022

Efficacy and Safety of Estetrol (E4), a Promising New Treatment for Menopausal Vasomotor Symptoms: Results of a randomized, double- blind, placebo-controlled Phase 3 trial (North American Menopause Society 2022 meeting 12-15 Oct, Atlanta, GA)

14 October 2022

Estetrol (E4), a landmark in the making? Before and beyond reproductive age: new therapeutic opportunities for E4 ⁠- Report on Scientific Symposium (20th ISGE World Congress)

13 June 2022

2021 Annual Results Webcast

8 March 2022

Donesta® Top-Line Results Phase 3

14 January 2022

2021 Investor Day Webcast

29 November 2021

2021 Half Year Results Webcast

24 September 2021

Share price

26/04/2024 17:35 (Euronext Brussels)

€ 0.22

0.00

(0.00%)

Calendar & events

General Shareholders’ Meeting
POSTPONED
30 May 2024
Half year results 2024
26 September 2024

Investor Relations

Get the latest news: subscribe to our Newsletter!